摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4Z)-4-({[4-(4-methylpiperazin-1-yl)phenyl]amino}methylene)-6-(2-phenylvinyl)isoquinoline-1,3(2H,4H)-dione | 1033330-40-3

中文名称
——
中文别名
——
英文名称
(4Z)-4-({[4-(4-methylpiperazin-1-yl)phenyl]amino}methylene)-6-(2-phenylvinyl)isoquinoline-1,3(2H,4H)-dione
英文别名
——
(4Z)-4-({[4-(4-methylpiperazin-1-yl)phenyl]amino}methylene)-6-(2-phenylvinyl)isoquinoline-1,3(2H,4H)-dione化学式
CAS
1033330-40-3
化学式
C29H28N4O2
mdl
——
分子量
464.567
InChiKey
RNISWZFWAGIIIB-HACAOAEASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.33
  • 重原子数:
    35.0
  • 可旋转键数:
    5.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    64.68
  • 氢给体数:
    2.0
  • 氢受体数:
    5.0

反应信息

  • 作为产物:
    描述:
    苯乙烯(4Z)-6-bromo-4-({[4-(4-methylpiperazin-1-yl)phenyl]amino}methylene)isoquinoline-1,3(2H,4H)-dione四丁基溴化铵 、 palladium diacetate 、 caesium carbonate三(邻甲基苯基)磷 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 0.03h, 以13%的产率得到(4Z)-4-({[4-(4-methylpiperazin-1-yl)phenyl]amino}methylene)-6-(2-phenylvinyl)isoquinoline-1,3(2H,4H)-dione
    参考文献:
    名称:
    4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as Potent and Selective Inhibitors of the Cyclin-Dependent Kinase 4 (CDK4)
    摘要:
    The cyclin-dependent kinases (CDKs), as complexes with their respective partners, the cyclins, are critical regulators of cell cycle progression. Because aberrant regulations of CDK4/cyclin D1 lead to uncontrolled cell proliferation, a hallmark of cancer, small-molecule inhibitors of CDK4/cyclin D1 are attractive as prospective antitumor agents. The series of 4-(phenylaminomethylene)isoquinoline-1,3(2H,4H)-dione derivatives reported here represents a novel class of potent inhibitors that selectively inhibit CDK4 over CDK2 and CDK1 activities. In the headpiece of the 4-(phenylaminomethylene)isoquinoline-1,3(2H,4H)dione, a basic amine substitutent is required on the aniline ring for the CDK4 inhibitory activity. The inhibitory activity is further enhanced when an aryl or heteroaryl substituent is introduced at the C-6 position of the isoquinoline-1,3(2H,4H)-dione core. We present here SAR data and a CDK4 mimic model that explains the binding, potency, and selectivity of our CDK4 selective inhibitors.
    DOI:
    10.1021/jm800072z
点击查看最新优质反应信息